Variation in elemental composition as influenced by chlorpyrifos application in mung bean (Vigna radiata L.)

AbstractChlorpyrifos (O,O-diethyl O-(3,5,6-trichloro-2-pyridyl) phosphorothioate), is an organophosphate insecticide effective against a broad spectrum of insect pests of economically important crops. The present study investigated the effects of chlorpyrifos application on sulfate assimilation and macro elemental composition in different plant parts at different phenological stages. Field experiments were conducted in the month of April 2008–2009. The individual plot size was 6m2 (4m×1.5m) having 4 rows with a row-to-row distance of 15inches and plant to plant distance of 10inches. The number of plants per m2 was 15. Seedlings were collected at 5 (preflowering), 10 (flowering) and 20 (postflowering) DAT (day after treatment) to analyze the effect of chlorpyrifos on APR activity and elemental composition. At harvest stage, seed from individual treatments were analyzed for sulfur containing amino acids like methionine and cysteine content. Twenty-day-old seedlings of Vigna radiata L. were subjected to chlorpyrifos at different concentrations ranging from 0 to 1.5mM through foliar spray in the field condition. A significant increase (50% in cysteine content and 50–92% in methionine content) in sulfur containing amino acids at a higher dose rate of 1.5mM was recorded in seeds, however the increased activity of adenosine 5-phosphosulfate reductase (APR), the key enzyme in sulfate assimilation was recorded in all the three parts of the plant (leaf, stem, root.). Transiently lower nitrogen, sulfur and carbon content in 0.6 and 1.5mM chlorpyrifos application in V. radiata L. supports the inhibition of metabolic processes. However, reverse trend was exhibited at 0.3mM for same parameters. These results suggest the stimulatory effects on sulfate assimilation in V. radiata L. while as inhibitory effects were prevalent on elemental composition

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Variation in elemental composition as influenced by chlorpyrifos application in mung bean (Vigna radiata L.)

Chlorpyrifos (O,O-diethyl O-(3,5,6-trichloro-2-pyridyl) phosphorothioate), is an organophosphate insecticide effective against a broad spectrum of insect pests of economically important crops. The present study investigated the effects of chlorpyrifos application on sulfate assimilation and macro elemental composition in different plant parts at different phenological stages. Field experiments were conducted in the month of April 2008–2009. The individual plot size was 6 m2 (4 m × 1.5 m) having 4 rows with a row-to-row distance of 15 inches and plant to plant distance of 10 inches. The number of plants per m2 was 15. Seedlings were collected at 5 (preflowering), 10 (flowering) and 20 (postflowering) DAT (day after treatment) to analyze the effect of chlorpyrifos on APR activity and elemental composition. At harvest stage, seed from individual treatments were analyzed for sulfur containing amino acids like methionine and cysteine content. Twenty-day-old seedlings of Vigna radiata L. were subjected to chlorpyrifos at different concentrations ranging from 0 to 1.5 mM through foliar spray in the field condition. A significant increase (50% in cysteine content and 50–92% in methionine content) in sulfur containing amino acids at a higher dose rate of 1.5 mM was recorded in seeds, however the increased activity of adenosine 5-phosphosulfate reductase (APR), the key enzyme in sulfate assimilation was recorded in all the three parts of the plant (leaf, stem, root.). Transiently lower nitrogen, sulfur and carbon content in 0.6 and 1.5 mM chlorpyrifos application in V. radiata L. supports the inhibition of metabolic processes. However, reverse trend was exhibited at 0.3 mM for same parameters. These results suggest the stimulatory effects on sulfate assimilation in V. radiata L. while as inhibitory effects were prevalent on elemental composition. Keywords: Green gram, Insecticide, Sulfur, Nitrogen, Carbon, Assimilatio

Synthesis and characterization of ternary carboxylato complexes of cobalt(II) with Schiff bases

2006-2010Some novel mixed-ligand, ternary carboxylato complexes of cobalt(II) with Schiff bases (HSB) having general formula [Co(OOCR)(SB)] (where R = C11H23, C13H27, C15H31 or C17H35) have been synthesized by the substitution reactions of anhydrous cobalt(II) acetate. The isolated products have been characterized by elemental analyses, molar conductance and magnetic moment measurements and spectral (infrared, electronic and FAB mass) data. Models and coordination hypotheses for the complexes have been proposed and a peculiar structural characterization has been discussed on the basis of physicochemical studies. A sharp structural change has been noticed

Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach

Epigallocatechin gallate (EGCG), the main ingredient in green tea, holds promise as a potential treatment for pulmonary arterial hypertension (PAH). However, EGCG has many drawbacks, including stability issues, low bioavailability, and a short half-life. Therefore, the purpose of this research was to develop and optimize an inhalable EGCG nano-liposome formulation aiming to overcome EGCG’s drawbacks by applying a design of experiments strategy. The aerodynamic behaviour of the optimum formulation was determined using the next-generation impactor (NGI), and its effects on the TGF-β pathway were determined using a cell-based reporter assay. The newly formulated inhalable EGCG liposome had an average liposome size of 105 nm, a polydispersity index (PDI) of 0.18, a zeta potential of −25.5 mV, an encapsulation efficiency of 90.5%, and a PDI after one month of 0.19. These results are in complete agreement with the predicted values of the model. Its aerodynamic properties were as follows: the mass median aerodynamic diameter (MMAD) was 4.41 µm, the fine particle fraction (FPF) was 53.46%, and the percentage of particles equal to or less than 3 µm was 34.3%. This demonstrates that the novel EGCG liposome has all the properties required to be inhalable, and it is expected to be deposited deeply in the lung. The TGFβ pathway is activated in PAH lungs, and the optimum EGCG nano-liposome inhibits TGFβ signalling in cell-based studies and thus holds promise as a potential treatment for PAH

Porous and nanofiber alpha-chitosan obtained from blue crab (Callinectes sapidus) tested for antimicrobial and antioxidant activities

WOS: 000364796700148Chitin was isolated using the classical chemical method from the shell of Callinectes sapidus. The chitin content in the dry weight of the crab shells was determined as 12.1%. Total chitosan yield was recorded as 76%. The deacetylation degree of the chitosan was found to be 82.5%. The obtained chitin was in the alpha-form which was confirmed from the results of FTIR, TGA and XRD analyses. Resulting chitin showed DTG max value as 390 degrees C while in same regard chitosan show this value as 306 degrees C. Detailed information about the composition of pores and nanofibers was obtained using SEM. Disc diffusion method used for testing the antimicrobial activity, inhibition zone diameters of the chitosan from C. sapidus varied between 15.28 and 20.21 mm for human bacterial pathogens, between 15.51 and 16.25 mm for fungal pathogens and between 14.22 and 15.75 mm for fish bacterial pathogens, respectively. MBC and MFC values of the chitosan from C sapidus were between 0.16 and 2.50 mg/mL. The results of DPPH and ferric ion reducing power activity used for determining the antioxidant activity of the chitosan, were found as IC50: 5.99 and EC50: 6.16, respectively. (C) 2015 Elsevier Ltd. All rights reserved